Inova Partners with NIH’s NHLBI on New Clinical Trial for Hospitalized COVID-19 Patients

abstract COVID image

Study enrollment complete with topline data expected in April 2021 Falls Church, VA – Inova Lung Services is part of a multicenter Phase 2 investigator-sponsored trial (IST) to evaluate the safety of fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of hospitalized COVID-19 patients. The study is in collaboration with the National…

Read More

COVID-19 and Children – Six Months In

boy with face mask looking at computer screen

Dr. Rick Place is Medical Director of the Pediatric Emergency Department at Inova Children’s Hospital (at Inova Fairfax Medical Campus in Falls Church, VA). Dr. Place is a board certified physician in both Emergency Medicine and Pediatrics. Although it feels like much longer, it has only been six months since the novel coronavirus SARS-CoV-2 was…

Read More

Inova Heart and Vascular Institute a Leading Contributor to National Care Guidelines During COVID-19 Pandemic

As COVID-19 began spreading across the U.S. in late February and early March, several physicians from Inova Heart and Vascular Institute (IHVI) were at the forefront of developing guidance that is now in use nationwide to direct cardiac care. “Our team’s dedication to assuring that cardiovascular patients receive timely and high quality care in a…

Read More

Radiation Oncologists Emerging as Unlikely Sleuths of Coronavirus

Doctor by proton therapy machine

During radiation treatment, doctors are picking up images that could indicate COVID-19 in patients who are asymptomatic. Inova Schar Cancer Institute’s Chairman and Medical Director of Radiation Oncology, Dr. Gopal Bajaj, spoke with Bloomberg Law about how radiation oncologists are emerging as the coronavirus’s unlikely sleuths. According to the April 2020 article, there have been…

Read More

Inova Schar Cancer Institute Physicians Lead Efforts in Optimizing Care and Treatment Approach for Patients during COVID-19 Pandemic

The COVID-19 outbreak is posing unprecedented risks and challenges for all communities and healthcare systems worldwide. Inova Schar Cancer Institute’s multidisciplinary team is continuously monitoring the rapidly changing COVID-19 situation. Our dedicated team of experts is up-to-date on developments and CDC guidelines, and has developed a comprehensive response plan to maintain the safety and well-being…

Read More